Burundi Essential Medical Devices List Teardown: ABREMA 2025
A data-driven teardown of Burundi's National Essential Medical Devices List (2025). Analyze the risk-class split, clinical-service mix, WHO-style tomes, and ABREMA legal framework.
Executive Summary
For medical device developers and global health procurement agencies, navigating the East African Community (EAC) requires navigating diverse national regulatory systems. While larger markets like Kenya and Tanzania rely on commercial registers, francophone low-resource markets utilize different instruments to manage market entry and public procurement. In Burundi, a francophone nation of 13 million people in East-Central Africa, the primary regulatory instrument driving public-sector access and donor procurement is the Liste Nationale des Dispositifs Médicaux Essentiels (LNDME).
According to our comprehensive database analysis of the official Liste Nationale des Dispositifs Médicaux Essentiels au Burundi (snapshot of the newly validated 2025 edition), the list contains exactly 923 essential device listings. Key findings from this quantitative teardown include:
- Low-Risk Profile: The list is heavily skewed toward low-risk technologies. Class A devices represent 482 listings (52.2%), followed by Class B with 226 (24.5%), Class C with 137 (14.8%), and Class D with just 21 (2.3%). An additional 57 records (6.2%) contain unpopulated or blank risk classifications, primarily corresponding to basic sutures and specialty clinical consumables. Combined, low-to-moderate risk devices (Class A and B) represent 76.7% of the entire list.
- Rehabilitation and Assistive Tech Dominance: Parsing the clinical specialty and medical-technical service fields reveals a striking focus on physical medicine. Médecine Physique et Réadaptation (physical medicine & rehab) is the largest clinical service, holding 328 listings (35.5%). This is followed by transversal / cross-cutting supplies with 107 (11.6%), dentistry (
Dentisterie) with 78 (8.5%), ophthalmology (Ophtalmologie) with 64 (6.9%), mobility aids with 47 (5.1%), and medical imaging with 46 (5.0%). - Specialty Tome Structure: Following the WHO essential-devices template, the database is organized into clinical-specialty tomes. Tome V (Internal Medicine) is the largest segment with 425 listings, followed by Tome XIV (Priority Assistive Technologies) with 179, dentistry (Tome XI) with 80, ENT/ORL (Tome XII) with 78, and ophthalmology (Tome XIII) with 64.
- EAC Integration and Alignment: The list is structured to align public-sector procurement with national treatment guidelines, matching the procurement schedules of the Central Purchasing Office (CAMEBU).
The legal basis for this list is established under Article 66 of Loi n° 1/012 du 30 mai 2018 (Code de l'Offre des Soins et Services de Santé), which mandates the Minister of Health to define the essential device mix. Regulatory oversight sits with ABREMA (Autorité Burundaise de Régulation des Médicaments à usage humain et des Aliments), created by Décret n° 100/039 du 26 février 2021 to modernize the regulation of both pharmaceuticals and medical technologies.
Introduction to Burundi's Healthcare System and Procurement Structure
Burundi's healthcare delivery system is organized hierarchically into health districts. Each district contains a network of primary health centers (Centres de Santé, CDS) serving local communities, and a district hospital (Hôpital de District) providing secondary care (general surgery, obstetrics, internal medicine). At the national level, tertiary care is provided by specialized referral hospitals in Bujumbura and Gitega.
Public-sector healthcare is heavily subsidized by the State and supported by international donors (World Bank, Global Fund, WHO, UNICEF). Procurement of clinical supplies, laboratory reagents, and medical equipment is managed through two main channels:
- CAMEBU (Centrale d'Achat des Médicaments Essentiels, des Dispositifs Médicaux et des Produits de Santé du Burundi): The state purchasing body responsible for importing and distributing essential health products to public health facilities. CAMEBU utilizes the National Essential List as its sole purchasing catalog.
- Direct Donor Procurement: International non-governmental organizations (NGOs) and bilateral aid programs procure devices directly for clinical programs (maternal health, infectious diseases, physical rehabilitation). These organizations require that all procured devices are listed on the national essential list to ensure regulatory compliance and integration with the national health system.
For a foreign manufacturer, being included on the LNDME is not merely an option—it is a pre-condition for market access. If a product code or device type is absent from the list, CAMEBU cannot include it in public tenders, and public laboratories cannot purchase it, effectively locking the manufacturer out of the public sector.
The Legal and Institutional Framework: Loi 1/012 and ABREMA
The regulation of medical technologies in Burundi is governed by a modernizing statutory framework:
1. Loi n° 1/012 du 30 mai 2018 (Code de l'Offre des Soins)
This law serves as the primary legislation for healthcare services and medical products. Article 66 states:
"Une liste des dispositifs médicaux est arrêtée par le Ministre ayant la santé publique dans ses attributions. Cette liste est soumise à révision chaque fois que de besoin." ("A list of medical devices is set by the Minister responsible for public health. This list is subject to revision whenever necessary.") This article establishes the essential list as an official regulatory instrument, ensuring that public resources are directed toward technologies that address the country's primary disease burdens and healthcare requirements.
2. The Creation of ABREMA (Décret n° 100/039 du 26 février 2021)
Historically, medical devices were unregulated, and customs clearance was managed through ad-hoc import permits. To address this, the government established the Autorité Burundaise de Régulation des Médicaments à usage humain et des Aliments (ABREMA) in February 2021. ABREMA is tasked with:
- Enforcing registration requirements for all imported medical products.
- Evaluating medical device dossiers for safety and quality (ISO 13485 compliance).
- Conducting vigilance audits on distributors and clinical users.
- Maintaining and updating the National Essential Medical Devices List in collaboration with the Ministry’s technical committees.
3. WHO Essential List Model Alignment
The LNDME follows the World Health Organization (WHO) model for essential medical devices, which is structured to reflect the level of care (primary, secondary, tertiary) and clinical specialty. This model ensures that high-risk, expensive equipment (such as CT scanners or cardiac catheters) is restricted to tertiary hospitals that have the necessary infrastructure and trained staff, while basic consumables and diagnostics are distributed to community health centers.
Database Teardown of the 2025 Essential List
Our database teardown of the 923 records in the 2025 Burundi LNDME reveals the clinical and risk-management priorities of the Burundian healthcare system:
1. Risk-Class Distribution
Unlike commercial registries where Class II and III devices dominate, Burundi's essential list is heavily skewed toward low-risk technologies:
| Risk Class | Description | active Listings | Percentage of Total | Core Product Types |
|---|---|---|---|---|
| Class A | Low Risk | 482 | 52.2% | Bandages, syringes, basic surgical instruments, splints |
| Class B | Moderate-Low Risk | 226 | 24.5% | Sutures, urinary catheters, dental fillings, basic diagnostics |
| Class C | Moderate-High Risk | 137 | 14.8% | Orthopedic implants, complex sutures, blood bags, IVDs |
| Class D | High Risk | 21 | 2.3% | Cardiac stents, pacemakers, surgical meshes, active implants |
| Blank / Unclassified | Pending classification | 57 | 6.2% | Long-tail consumables, specialty orthopedic parts |
| Total List | 923 | 100.0% |
Burundi Essential List Risk Class Split:
Class A: [==================================================] 482 (52.2%)
Class B: [========================] 226 (24.5%)
Class C: [==============] 137 (14.8%)
Class D: [==] 21 (2.3%)
Class A and B devices represent 76.7% of the entire database, confirming the list's focus on primary care and clinical consumables. High-risk Class D devices account for just 2.3% (21 listings), reflecting the limited capacity of Burundi's tertiary hospitals to support complex cardiac or neurological interventions.
2. Clinical Specialty Breakdown (Service_medical_technical)
The distribution of devices across medical specialties highlights Burundi's specific health-system priorities:
| Rank | Clinical Specialty (French) | English Translation | Listings | Percentage |
|---|---|---|---|---|
| 1 | Médecine Physique et Réadaptation |
Physical Medicine & Rehabilitation | 328 | 35.5% |
| 2 | Transversal |
Cross-cutting / General Wards | 107 | 11.6% |
| 3 | Dentisterie |
Dentistry / Stomatology | 78 | 8.5% |
| 4 | Ophtalmologie |
Ophthalmology | 64 | 6.9% |
| 5 | Mobilité |
Mobility & Assistive Devices | 47 | 5.1% |
| 6 | Imagerie Médicale |
Medical Imaging (X-Ray, Ultrasound) | 46 | 5.0% |
| 7 | Consultation |
Outpatient / Basic Diagnostic Tools | 35 | 3.8% |
| 8 | Chirurgie |
General Surgery / Operating Theatre | 30 | 3.3% |
| 9 | Amygdalectomie |
Tonsillectomy Specialty Set | 26 | 2.8% |
| 10 | Planification Familiale |
Reproductive Health / Family Planning | 25 | 2.7% |
| Other | Various Specialties | 137 | 14.8% | |
| Total | 923 | 100.0% |
Burundi Top Specialties Share:
Physical Rehab: [====================================] 328 (35.5%)
Transversal: [===========] 107 (11.6%)
Dentistry: [========] 78 (8.5%)
Ophthalmology: [======] 64 (6.9%)
The dominance of Physical Medicine & Rehabilitation (328 listings, 35.5%) and Mobility Aids (47 listings, 5.1%) is the most striking feature of the Burundi database. Combined, rehabilitation technologies represent 40.6% of the entire list. This is a direct reflection of long-term international donor programs (led by organizations such as Humanity & Inclusion and the ICRC) working to establish physical rehabilitation infrastructure for patients with congenital disorders, trauma injuries, and war-related amputations.
3. Specialty Tome Structure
Following the WHO essential-devices template, the database is organized into clinical-specialty tomes:
| Tome Number | Specialty Scope (French) | Listings | Core Products |
|---|---|---|---|
| TOME V | Dispositifs Médicaux pour la Médecine Interne | 425 | General ward consumables, syringes, IV sets |
| TOME XIV | Liste des aides techniques prioritaires | 179 | Wheelchairs, prosthetics, crutches, hearing aids |
| TOME XI | Dispositifs pour la Stomatologie/Dentisterie | 80 | Dental alloys, fillings, crowns, basic drills |
| TOME XII | Dispositifs Médicaux pour ORL | 78 | Otoscopes, ear speculums, tracheostomy tubes |
| TOME XIII | Dispositifs Médicaux pour l’Ophtalmologie | 64 | Lenses, ophthalmic drops, cataract extraction kits |
| Other | Various Tomes (Pediatrics, Gynecology) | 97 | Specialty surgical sets, incubators, IUDs |
| Total | 923 |
The tome analysis confirms that Tome V (Internal Medicine) is the largest segment with 425 listings (46.0%), representing the high-volume consumables required by all hospital wards and health centers. Tome XIV (Priority Assistive Technologies) holds 179 listings (19.4%), providing the detailed technical specifications for mobility, vision, and hearing aids.
In-Depth Analysis: The 35.5% Physical Medicine & Rehabilitation Focus
The presence of physical rehabilitation as the single largest clinical category (328 items, 35.5%) warrants close strategic inspection. In most medical device registers, physical medicine accounts for less than 3% of active listings. Why does it occupy more than a third of Burundi's essential list?
The answer lies in the intersection of public-health policy, historical trauma, and international donor financing. Burundi experienced decades of civil conflict and regional instability, leaving a substantial population with physical disabilities and amputation-related mobility challenges. In response, the Ministry of Health, in partnership with international agencies, made physical medicine a priority health program.
This resulted in the systematic expansion of Tome XIV (Priority Assistive Technologies) and the rehabilitation sections of Tome V. The register includes a highly detailed list of:
- Prosthetic and Orthotic Components: Pre-fabricated joints, pylons, straps, and specialized thermoplastic sheets used to fabricate custom orthoses in local workshops (such as the Bujumbura Rehabilitation Center).
- Mobility Aids: Specific classes of manual wheelchairs designed for rough terrain, pediatric wheelchairs, crutches (axillary and forearm), walking frames, and canes.
- Sensory and Communication Aids: Hearing aids, magnifying lenses, braille slates, and white canes.
For foreign manufacturers of assistive technologies, this indicates that the Burundian public sector has a highly developed, structured procurement framework. The listings are detailed down to the material composition (e.g., high-density polyethylene sheets, stainless steel joints), ensuring that procured products can survive the environmental conditions of rural health centers.
Understanding the Essential-List vs. Commercial-Register Dualism
For regulatory managers, it is crucial to distinguish between the two types of databases:
- Burundi LNDME (Essential List): This database is a curated, need-based list. It does not reflect all products registered for commercial sale in the country. Instead, it defines the subset of devices that the government and donors agree are essential for public health. To be listed, a device must offer proven clinical utility, cost-effectiveness, and compatibility with local infrastructure.
- Commercial Registries (e.g., Kenya PPB, Tanzania TMDA): These are market-driven registries. Any manufacturer that meets safety and quality standards can register their device, regardless of whether the country "needs" it. The commercial registry has no volume limit and covers all private-market sales.
This dualism dictates the market access strategy: in Burundi, commercial registration with ABREMA is necessary to import the device, but LNDME listing is required to sell the device to the public sector (CAMEBU) and international donor programs, which together represent the majority of the medical device market by value in a low-resource, donor-funded health system.
Transposing WHO Selection Criteria into Burundian Practice
The Burundian Ministry of Health does not compile the LNDME in a vacuum. Under Article 66, the technical committees use a structured adaptation of the WHO Selection Guidelines for Essential Health Technologies. This transposition follows five core parameters:
- Public Health Relevance: The device must target a primary disease burden or physical disability prevalent in the population. This explains the extensive listing of obstetric tools, malaria diagnostic accessories, and physical rehabilitation components.
- Technical and Operational Safety: The device must demonstrate a proven safety profile. This is checked via ISO 13485 certifications and marketing authorizations from Stringent Regulatory Authorities (SRA).
- Infrastructure Compatibility: The technical committee audits whether the device requires continuous electricity, clean water, or specific environmental controls (such as air conditioning) that are unavailable at the primary care level. If a device has high infrastructure requirements, it is restricted to Tome XV (national hospitals).
- Cost-Effectiveness and Sustainability: The purchase price is evaluated alongside the total cost of ownership, including reagents, replacement parts, and maintenance training. Preference is given to open systems that allow local technicians to perform repairs without proprietary software keys.
- Local Training Feasibility: The committee evaluates whether Burundian clinical staff (often nurses or clinical officers in rural areas) can be trained to use the device safely without requiring long-term academic specialization.
Step-by-Step LNDME Listing Workflow for Burundi
For a foreign manufacturer seeking to list a device on the Burundi National Essential List, the process follows a structured path:
- Step 1: Obtain ABREMA Commercial Registration: Before applying for LNDME inclusion, the device must hold a valid commercial registration with ABREMA. This requires appointing a licensed local representative (LTR) in Bujumbura, submitting a technical dossier (ISO 13485, CE mark/FDA, packaging labels), translating instructions into French, and paying the evaluation fee.
- Step 2: Compile LNDME Technical Application: The LTR compiles a dedicated dossier for the Ministry’s technical committee. This dossier must include clinical trial summaries, comparative pricing data, and evidence of compatibility with local health center infrastructure.
- Step 3: Submit to the Technical Secretariat: The LTR files the application with the Technical Secretariat of the Commission Nationale des Médicaments et Dispositifs Médicaux. The application must explicitly state which Tome and clinical specialty slot the product is targeting.
- Step 4: Annual Evaluation and Desk Review: The Commission meets once a year to review applications. They assess whether the proposed device provides superior utility or lower pricing than the items currently listed.
- Step 5: Ministerial Signature and Publication: Once approved, the commission includes the item in the draft LNDME update. The Minister of Public Health signs the official decree, publishing the new edition and adding the listings to CAMEBU’s procurement schedules.
Comparative Analysis: East African Community (EAC) Pathways
How does Burundi's essential-list pathway compare with its regional neighbors in the East African Community? The table below maps the differences:
| Regulatory Feature | Burundi (ABREMA / LNDME) | Kenya (PPB) | Tanzania (TMDA) | DR Congo (ACOREP) |
|---|---|---|---|---|
| Primary Regulator | ABREMA / Ministry of Health | Pharmacy and Poisons Board (PPB) | Tanzania Medicines & Devices Authority | ACOREP / Ministry of Health |
| Database Type | Essential List + Register | Commercial Registry | Commercial Registry | Commercial Import Register |
| Total Listings | 923 active essential devices | ~12,000 commercial devices | ~8,000 commercial devices | ~3,500 import approvals |
| Language Gate | French (labels, IFU, manual) | English | English (plus Swahili for home use) | French |
| EAC Integration | Aligning with EAC guidelines | Active EAC harmonization | Active EAC harmonization | SADC observer, standalone |
| Procurement Link | Direct (sole source for CAMEBU) | Indirect (KEMSA uses register) | Indirect (MSD uses registry) | Indirect (public tenders use register) |
| Rehab/Physio Focus | High (35.5% of list) | Low (general medical focus) | Low (general medical focus) | Low (consumables focus) |
Burundi's pathway differs significantly from the systems in Kenya and Tanzania. As analyzed in our Kenya PPB retained medical devices teardown and the Tanzania TMDA medical device registry analysis, these Anglophone markets use extensive commercial registries with thousands of active listings.
In contrast, Burundi utilizes a targeted essential list (923 devices) to manage public health procurement. Furthermore, Burundi enforces strict French-language compliance gates for all documentation, matching the requirements of the DR Congo ACOREP medical device register analysis.
Strategic Recommendations for Manufacturers Targeting Burundi
To navigate the Burundian market successfully, manufacturers should adopt the following strategies:
1. Leverage Rehabilitation and Assistive Tech Priorities
Given that physical rehabilitation represents 35.5% of the essential list, manufacturers of splints, braces, prosthetics, and mobility aids should prioritize Burundi. Inclusion in Tome XIV is highly streamlined due to established donor-funded clinical networks.
- Action: Partner with international NGOs (such as the ICRC or Humanity & Inclusion) to co-submit applications. Ministry committees prioritize devices that are backed by an active clinical program with committed donor funding.
2. Reconcile Blank Risk Classifications
Our analysis identified 57 records with blank risk classifications. Importers bidding on CAMEBU tenders for these items must proactively request a formal classification letter from ABREMA's technical department to prevent administrative customs delays.
3. Focus on French-Language Packaging and IFUs
Burundi enforces strict language policies. All user instructions, safety labeling, and software interfaces must be provided in French. Machine-translated text is heavily audited; manufacturers should use professional translation services to prevent dossier rejections.
4. Design for Low-Resource Settings
Manufacturers should ensure their devices are optimized for low-resource environments. Products that do not require continuous power, use standard non-proprietary consumables, and are easy to clean and sanitize have a significantly higher chance of being approved by the technical committee.
Frequently Asked Questions (FAQs)
Is the Burundi essential devices list a commercial registration register?
No. The LNDME is a curated list of medical devices deemed essential for Burundi's public health needs. While commercial registration with ABREMA is required to import any medical device, inclusion on the LNDME is required to sell products to the public sector (CAMEBU) and donor-funded programs.
What is ABREMA and what role does it play?
ABREMA (Autorité Burundaise de Régulation des Médicaments à usage humain et des Aliments) is the national regulatory authority established in 2021. It manages the registration dossiers for medical products, enforces quality standards (ISO 13485), and oversees post-market vigilance.
Why are rehabilitation and Class A devices so dominant on the list?
Burundi's healthcare priorities are focused on primary care and physical rehabilitation, supported by long-term donor programs. Class A and B consumables make up 76.7% of the list, while physical medicine and mobility aids account for over 40% of all listings.
How often is the Burundi LNDME updated?
Under Article 66 of the Code de l'Offre des Soins, the list is "subject to revision whenever necessary" (révision chaque fois que de besoin). In practice, the technical committees meet periodically to review new submissions and compile proposed additions for a new edition.
References
- Loi n° 1/012 du 30 mai 2018 portant Code de l'Offre des Soins et Services de Santé au Burundi, République du Burundi.
- Décret n° 100/039 du 26 février 2021 portant Création, Organisation et Fonctionnement de l'Autorité Burundaise de Régulation des Médicaments et des Aliments (ABREMA), Bujumbura.
- Liste Nationale des Dispositifs Médicaux Essentiels au Burundi, Édition 2025, Ministère de la Santé Publique et de la Lutte contre le Sida. Official PDF on Minisante portal.
- WHO Model List of Essential Medical Devices, World Health Organization, Geneva, 2024.
- Plan National de Développement Sanitaire du Burundi (PNDS III), Ministère de la Santé Publique, Bujumbura, 2023.
- East African Community (EAC) Harmonized Guidelines for Medical Devices Registration, EAC Secretariat, Arusha, 2024.